Skn-1a/Oct-11 and ΔNp63α exert antagonizing effects on human keratin expression

Biochemical and Biophysical Research Communications

Volumn 401, Issue 4, 2010, Pages 568-573

  Lena, Anna Maria ^a   Cipollone, Rita ^a   Amelio, Ivano ^a   Catani, Maria Valeria ^a   Ramadan, Safaa ^a   Browne, Gareth ^b   Melino, Gerry ^a,b   Candi, Eleonora ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Differentiation; Epidermal stratification; P63; POU domain protein; Skn 1a

Indexed keywords

KERATIN; OCTAMER TRANSCRIPTION FACTOR; OCTAMER TRANSCRIPTION FACTOR 11; PROTEIN P63; TRANSCRIPTION FACTOR POU; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOCALIZATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SKIN BIOPSY; TRANSACTIVATION;

CELL DIFFERENTIATION; CELL LINE; EPIDERMIS; HUMANS; IMMUNOPRECIPITATION; KERATIN-10; KERATIN-14; KERATINOCYTES; KERATINS; OCTAMER TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 77958479635     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.102     Document Type: Article

References (45)

1. Fuchs E., Byrne C. The epidermis: rising to the surface. Curr. Opin. Genet. Dev. 1994, 4:725-736.
2. Candi E., Schmidt R., Melino G. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 2005, 6:328-340.
3. Paus R., Rosenbach T., Haas N., Czarnetzki B.M. Patterns of cell death: the significance of apoptosis for dermatology. Exp. Dermatol. 1993, 2:3-11.
4. Haake A.R., Polakowska R.R. Cell death by apoptosis in epidermal biology. J. Invest. Dermatol. 1993, 101:107-112.
5. Polakowska R.R., Piacentini M., Bartlett R., Goldsmith L.A., Haake A.R. Apoptosis in human skin development: morphogenesis, periderm, and stem cells. Dev. Dyn. 1994, 199:176-188.
6. Fuchs E. Keratins and the skin. Annu. Rev. Cell Dev. Biol. 1995, 11:123-153.
7. Angel P., Szabowski A., Schorpp-Kistner M. Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 2001, 20:2413-2423.
8. Yamada K., Yamanishi K., Kakizuka A., Kibe Y., Doi H. H.Yasuno, Transcriptional regulation of human transglutaminase1 gene by signaling systems of protein kinase C, RAR/RXR and Jun/Fos in keratinocytes. Biochem. Mol. Biol. Int. 1994, 34:827-936.
9. Bikle D.D., Tu C.L., Xie Z., Oda Y. Vitamin D regulated keratinocyte differentiation: role of coactivators. J. Cell. Biochem. 2003, 88:290-295.
10. Hurlin P.J., Ayer D.E., Grandori C., Eisenman R.N. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harb. Symp. Quant. Biol. 1994, 59:109-116.
11. Herr W., Sturm R.A., Clerc R.G., Corcoran L.M., Baltimore D., Sharp P.A., Ingraham H.A., Rosenfeld M.G., Finney M., Ruvkun G., Horvitz H.R. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev. 1988, 2:1513-1516.
12. Klemm J.D., Rould M.A., Aurora R., Herr W., Pabo C.O. Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell 1994, 77:21-32.
13. Scholer H.R. Octamania: the POU factors in murine development. Trends Genet. 1991, 7:323-329.
14. Veenstra G.J., van der Vliet P.C., Destree O.H. POU domain transcription factors in embryonic development. Mol. Biol. Rep. 1997, 24:139-155.
15. Phillips K., Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J. Mol. Biol. 2000, 302:1023-1039.
16. Andersen B., Schonemann M.D., Flynn S.E., Pearse R.V., Singh H., Rosenfeld M.G. Skn-1a and Skn-1i: two functionally distinct Oct-2-related factors expressed in epidermis. Science 1993, 260:78-82.
17. Andersen B., Hariri A., Pittelkow M.R., Rosenfeld M.G. Characterization of Skn-1a/i POU domain factors and linkage to papillomavirus gene expression. J. Biol. Chem. 1997, 272:15905-15913.
18. Andersen B., Weinberg W.C., Rennekampff O., McEvilly R.J., Bermingham J.R., Hooshmand F., Vasilyev V., Hansbrough J.F., Pittelkow M.R., Yuspa S.H., Rosenfeld M.G. Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev. 1997, 11:1873-1884.
19. Faus I., Hsu H.J., Fuchs E. Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol. Cell. Biol. 1994, 14:3263-3275.
20. Goldsborough A.S., Healy L.E., Copeland N.G., Gilbert D.J., Jenkins N.A., Willison K.R., Ashworth A. Cloning, chromosomal localization and expression pattern of the POU domain gene Oct-11. Nucleic Acids Res. 1993, 21:127-134.
21. Yukawa K., Yasui T., Yamamoto A., Shiku H., Kishimoto T., Kikutani H. Epoc-1: a POU-domain gene expressed in murine epidermal basal cells and thymic stromal cells. Gene 1993, 133:163-169.
22. Bermingham J.R., Scherer S.S., O'Connell S., Arroyo E., Kalla K.A., Powell F.L., Rosenfeld M.G. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev. 1996, 10:1751-1762.
23. Jaegle M., Mandemakers W., Broos L., Zwart R., Karis A., Visser P., Grosveld F., Meijer D. The POU factor Oct-6 and Schwann cell differentiation. Science 1996, 273:507-510.
24. Ryan A.K., Rosenfeld M.G. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev. 1997, 11:1207-1225.
25. Herr W., Cleary M.A. The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 1995, 9:1679-1693.
26. Verrijzer C.P., Van der Vliet P.C. POU domain transcription factors. Biochim. Biophys. Acta 1993, 1173:1-21.
27. Wegner M., Drolet D.W., Rosenfeld M.G. POU-domain proteins: structure and function of developmental regulators. Curr. Opin. Cell Biol. 1993, 5:488-498.
28. Fischer D.F., Gibbs S., van De Putte P., Backendorf C. Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation. Mol. Cell Biol. 1996, 16:5365-5374.
29. Hildesheim J., Foster R.A., Chamberlin M.E., Vogel J.C. Characterization of the regulatory domains of the human Skn-1a/Epoc-1/Oct-11 POU transcription factor. J. Biol. Chem. 1999, 274:26399-26406.
30. Welter J.F., Gali H., Crish J.F., Eckert R.L. Regulation of human involucrin promoter activity by POU domain proteins. J. Biol. Chem. 1996, 271:14727-14733.
31. Jang S., Karaman-Jurukovska N., Morasso M.I., Steinert P.M., Markova N.G. Complex interactions between epidermal POU domain and activator protein 1 transcription factors regulate the expression of profilaggrin gene in normal human epidermal keratinocytes. J. Biol. Chem. 2000, 275:15295-15304.
32. Sugihara T.M., Kudryavtseva E.I., Kumar V., Horridge J.J., Andersen B. The POU domain factor Skin-1a represses the keratin 14 promoter independent of DNA binding. A possible role for interactions between Skn-1a and CREB-binding protein/p300. J. Biol. Chem. 2001, 276:33036-33044.
33. Candi E., Cipollone R., Rivetti di Val Cervo P., Gonfloni S., Melino G., Knight R. P63 in epithelial development. Cell Mol. Life Sci. 2008, 6:3126-3133.
34. Melino G., Lu X., Gasco M., Crook T., Knight R.A. Functional regulation of p73 and p63: development and cancer. Trends Biochem. Sci. 2003, 28:663-670.
35. Zaika A.I., Slade N., Erster S.H., Sansome C., Joseph T.W., Pearl M., Chalas E., Moll U.M. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J. Exp. Med. 2002, 196:765-780.
36. Melino G., De Laurenzi V., Vousden K.H. P73: friend or foe in tumorigenesis. Nat. Rev. Cancer 2002, 2:605-615.
37. Senoo M., Pinto F., Crum C.P., McKeon F. P63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007, 4:523-536.
38. Candi E., Rufini A., Terrinoni A., Giamboi-Miraglia A., Lena A.M., Mantovani R., Knight R., Melino G. DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. Proc. Natl. Acad. Sci. USA 2007, 104:11999-12004.
39. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., Drews N.C., Caput D., McKeon F. P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 1998, 2:305-316.
40. Faridoni-Laurens L., Bosq J., Janot F., Vayssade M., Le Bihan M.L., Kaghad M., Caput D., Benard J., Ahomadegbe J.C. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?. Oncogene 2001, 20:5302-5312.
41. Candi E., Rufini A., Terrinoni A., Dinsdale D., Ranalli M., Paradisi A., De Laurenzi V., Spagnoli L.G., Catani M.V., Ramadan S., Knight R.A., Melino G. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ. 2006, 13:1037-1047.
42. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., McKeon F. P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999, 398:714-718.
43. Pellegrini G., Dellambra E., Golisano O., Martinelli E., Fantozzi I., Bondanza S., Ponzin D., McKeon F., De Luca M. P63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 2001, 98:3156-3161.
44. Rinne T., Brunner H.G., van Bokhoven H. p63-associated disorders. Cell Cycle 2007, 6:262-268.
45. Baranek C., Sock E., Wegner M. The POU protein Oct-6 is a nucleocytoplasmic shuttling protein. Nucleic Acids Res. 2005, 33:6277-6286.